Sign in

CIK 0001621227

  • Non-accelerated filer
  • Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 1235430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
  1. 4 Open-market buy 10% owner bought 6,571,164 shares at an average $1.92 ($12,587,753)
  2. 4 Open-market buy 10% owner bought 6,571,164 shares at an average $1.92 ($12,587,753)
  3. 4 Open-market buy 10% owner bought 6,571,164 shares at an average $1.92 ($12,587,753)
  4. 4 Open-market buy 10% owner bought 1,268,508 shares at an average $1.91 ($2,417,847)
  5. 4 Open-market buy 10% owner bought 1,268,508 shares at an average $1.91 ($2,417,847)
  6. 4 Open-market buy 10% owner bought 1,268,508 shares at an average $1.91 ($2,417,847)
  7. 4 Open-market buy Director bought 1,268,508 shares at an average $1.91 ($2,417,847)
  8. 4 Open-market buy 10% owner bought 1,268,508 shares at an average $1.91 ($2,417,847)
  9. 4 Open-market buy 10% owner bought 1,268,508 shares at an average $1.91 ($2,417,847)
  10. 4 Open-market buy 10% owner bought 1,268,508 shares at an average $1.91 ($2,417,847)
  11. 4 Open-market buy 10% owner bought 1,268,508 shares at an average $1.91 ($2,417,847)
  12. 4 Open-market buy 10% owner bought 1,268,508 shares at an average $1.91 ($2,417,847)
  13. 4 Open-market buy 10% owner bought 1,268,508 shares at an average $1.91 ($2,417,847)
  14. 4 Open-market sale Chief Financial Officer sold 600,000 shares at $1.71 ($1,026,000)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 14 of 18 · 351 filings